Subject
Editions published in Nature Cancer 110
-
Author Correction: Breaking the performance ceiling for neoantigen immunogenicity prediction
-
Somatic mouse models of gastric cancer reveal genotype-specific features of metastatic disease
-
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome
-
Publisher Correction: Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment
-
Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment
-
A palmitate-rich metastatic niche enables metastasis growth via p65 acetylation resulting in pro-metastatic NF-κB signaling
-
Multimodal immunogenomic biomarker analysis of tumors from pediatric patients enrolled to a phase 1-2 study of single-agent atezolizumab
-
Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment
-
An anti-PD-1-GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy
-
MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis
-
Perivascular tenascin C triggers sequential activation of macrophages and endothelial cells to generate a pro-metastatic vascular niche in the lungs
-
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
-
A new sophistication for breast cancer PDXs
-
Form follows function in cancer genomes
-
SETD2 loss perturbs the kidney cancer epigenetic landscape to promote metastasis and engenders actionable dependencies on histone chaperone complexes
-
Mesenchymal and adrenergic cell lineage states in neuroblastoma possess distinct immunogenic phenotypes
-
Few-shot learning creates predictive models of drug response that translate from high-throughput screens to individual patients
-
Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities
-
Pharmacological disruption of the MTDH–SND1 complex enhances tumor antigen presentation and synergizes with anti-PD-1 therapy in metastatic breast cancer
-
Eliminating cervical cancer in the COVID-19 era
-
Low neoantigen expression and poor T-cell priming underlie early immune escape in colorectal cancer
-
Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders
-
Complement activation promoted by the lectin pathway mediates C3aR-dependent sarcoma progression and immunosuppression
-
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms
-
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study
-
Melanoma-derived small extracellular vesicles induce lymphangiogenesis and metastasis through an NGFR-dependent mechanism
-
Clonal expansion of T memory stem cells determines early anti-leukemic responses and long-term CAR T cell persistence in patients
-
Bone marrow NG2<sup>+</sup>/Nestin<sup>+</sup> mesenchymal stem cells drive DTC dormancy <i>via</i> TGFβ2
-
ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancer
-
Small-molecule inhibitors that disrupt the MTDH-SND1 complex suppress breast cancer progression and metastasis
-
Spatial proteomic characterization of HER2-positive breast tumors through neoadjuvant therapy predicts response
-
Integrating molecular profiles into clinical frameworks through the Molecular Oncology Almanac to prospectively guide precision oncology
Subject - wd:Q96319263